Investing in cancer care in the UK: why aren't we acting on the evidence?

Zachary J. Ward; Rifat Atun; Ajay Aggarwal; Mark Lawler; Hedvig Hricak

doi:10.1016/S1470-2045(24)00634-X

Investing in cancer care in the UK: why aren't we acting on the evidence?

Zachary J. Ward
, Rifat Atun
, Ajay Aggarwal
, Mark Lawler
, Hedvig Hricak

Medicine, Health and Life Sciences

Research output: Contribution to journal › Comment/debate › peer-review

6 Citations (Scopus)

Original language	English
Pages (from-to)	1522-1524
Number of pages	3
Journal	The Lancet Oncology
Volume	25
Issue number	12
DOIs	https://doi.org/10.1016/S1470-2045(24)00634-X
Publication status	Published - 02 Dec 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

Oncology

Access to Document

10.1016/S1470-2045(24)00634-XLicence: Unspecified

Cite this

@article{85b97e0f3b3a44a288d0176930941caf,

title = "Investing in cancer care in the UK: why aren't we acting on the evidence?",

author = "Ward, \{Zachary J.\} and Rifat Atun and Ajay Aggarwal and Mark Lawler and Hedvig Hricak",

year = "2024",

month = dec,

day = "2",

doi = "10.1016/S1470-2045(24)00634-X",

language = "English",

volume = "25",

pages = "1522--1524",

journal = "The Lancet Oncology",

issn = "1470-2045",